Brokerages like Citi and Choice Institutional Equities are optimistic about the pharmaceutical and flexible workspace sectors ...

Mumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has ...

The Nifty Pharma index was trading slightly lower at 22,529.20, down 0.23 per cent, reflecting mixed sentiment across ...

Mumbai: Lupin has announced that the company has received seven observations from the U.S. Food and Drug Administration ...

Lupin Ltd, a pharma stock, has broken out of a 7-month consolidation, signaling a potential bull comeback. Experts suggest ...

Lupin is one of India’s leading multinational pharmaceutical companies, headquartered in Mumbai. Known for its presence in ...

Even as other drugmakers are making big plays for business in Japan, India’s Lupin is backing off. Just weeks after selling the sterile manufacturing assets of its Kyowa operation, it has now unloaded ...

Indian Pharma Q2 growth driven by Domestic (7.3%) & CDMO (+23%) business. Nuvama 'Buy' picks: Ajanta (₹3,250), Divi's Labs ...

The drug is indicated for the treatment of schizophrenia and for additional maintenance treatment of bipolar disorder.

Lupin Share Price Target 2025: Global brokerage Jefferies has maintained its buy rating on Lupin with a target price of Rs ...

Lupin Foundation earns CRISIL’s highest VO 1A rating for excellence in social responsibility: Our Bureau, Mumbai Friday, November 28, 2025, 16:10 Hrs [IST] Lupin Human Welfare a ...

India's pharmaceutical manufacturing industry is no stranger to the novel coronavirus after multiple waves of infections have temporarily shut down operations at a number of drugmakers' sites. Now, a ...